ORPHA:1816
Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome
Also known as: Berlin syndrome · Ectodermal dysplasia, Berlin type
Publications
7
18.9th percentile
Trials
0
Interventional, condition-specific
Researchers
39
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
Leukomelanoderma-infantilism--hypodontia-hypotrichosis syndrome is a rare ectodermal syndrome characterized by generalized melanoleukoderma, hypodontia and hypotrichosis associated with infantilism, and growth delay. There have been no further descriptions in the literature since 1961.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0009522
- MeSH:C565440
- OMIM:246500
- UMLS:C1855504
Additional Mondo synonyms (3)
LEUKOMELANODERMA, infantilism, intellectual disability, hypodontia, hypotrichosis · LEUKOMELANODERMA, infantilism, mental retardation, hypodontia, hypotrichosis · ectodermal dysplasia, Berlin type
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
7 matched papers (4 in last 10 years) Source
- Phenotype characterisedPresent
16 HPO annotations (e.g. Hypospadias; Intellectual disability; Generalized hirsutism) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
16
Associated phenotypes · MONDO:0009522
- Hypospadias
- Intellectual disability
- Generalized hirsutism
- Short stature
- Irregular hyperpigmentation
Showing 5 of 16 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
7
7 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
7 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
4 in the last 10 years · high confidence · 18.9th percentile (publications denominator)
Phrase hits: 7 · MeSH hits: 0
Who's working on it?
39
Distinct author names in 7 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Abu-Akel AM1 paper · 2015
School of Psychology, University of Birmingham, Edgbaston B15 2TT, UK ama289@bham.ac.uk.
Papers in Europe PMC - 02Al-Choboq J1 paper · 2022
Inserm, U1296 Unit, Radiation: Defense, Health and Environment, Centre Léon-Bérard, 69008 Lyon, France.
Papers in Europe PMC - 03Apperly IA1 paper · 2015
School of Psychology, University of Birmingham, Edgbaston B15 2TT, UK.
Papers in Europe PMC - 04Attinà G1 paper · 2022
Pediatric Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 00168 Rome, Italy.
Papers in Europe PMC - 05Berthel E1 paper · 2022
Inserm, U1296 Unit, Radiation: Defense, Health and Environment, Centre Léon-Bérard, 69008 Lyon, France.
Papers in Europe PMC - 06Bourguignon M1 paper · 2022
Inserm, U1296 Unit, Radiation: Defense, Health and Environment, Centre Léon-Bérard, 69008 Lyon, France.
Papers in Europe PMC - 07Capozza MA1 paper · 2022
Pediatric Oncology Unit, Department of Pediatric Oncology, Santobono-Pausilipon Children's Hospital, via Posillipo n° 226, 80123 Naples, Italy.
Papers in Europe PMC - 08Cinalli G1 paper · 2022
Pediatric Neurosurgery Unit, Department of Pediatric Neurosciences, Santobono-Pausilipon Children's Hospital, via M. Fiore n° 6, 80129 Naples, Italy.
Papers in Europe PMC - 09Cioffi D1 paper · 2022
Pediatric Endocrinology Unit, Department of Pediatrics, Santobono-Pausilipon Children's Hospital, via M. Fiore n° 6, 80129 Naples, Italy.
Papers in Europe PMC - 10De Martino L1 paper · 2022
Neurooncology Unit, Department of Pediatric Oncology, Santobono-Pausilipon Children's Hospital, via M. Fiore n° 6, 80129 Naples, Italy.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 41 · after dedupe 41 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 41 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (41)
- ctis·2024-512632-30-00·Authorised, ongoing·A prospective, open-label, genotype-match controlled, multicenter clinical trial to investigate the efficacy and safety of intra-amniotic ER004 as a prenatal treatment for male subjects with X-linked hypohidrotic ectodermal dysplasia (XLHED)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12510191·Not yet recruiting·A feasibility study of a smartphone app to support mental well-being in people with Long COVID
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN70543115·Recruiting·A study to see whether the lungs of very sick patients on an artificial lung machine heal more quickly with slower, deeper breathing
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN21010160·No longer recruiting·Bedside nose-to-intestine feeding with easily digested liquid nutrition for adults with acute respiratory distress and bleeding in the upper stomach or gut
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16516753·No longer recruiting·Can a nebulized medication reduce death rates in adults with severe lung failure on ventilators?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN67912485·No longer recruiting·Risk assessment for chronic coronary heart disease by general practitioners: Using the Cardio Explorer in primary care
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN35042256·No longer recruiting·Efficacy and tolerability of tasipimidine in sleepless patients
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN71534700·No longer recruiting·Assessing heart problems in psoriasis patients using cardiovascular magnetic resonance (CMR) imaging
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36798599·Recruiting·Phase II, double-blind, randomized, placebo-controlled, multicentre study to evaluate the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN93026854·No longer recruiting·Comparability study of anifrolumab administered using a medical device in healthy volunteers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17672960·No longer recruiting·A study to assess the safety of selnoflast in participants with chronic obstructive pulmonary disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16847938·No longer recruiting·A study to evaluate the safety, tolerability, processing by the body and mechanism of action of RO7486967 in participants with ulcerative colitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN31812808·No longer recruiting·Cardiac magnetic resonance shows a different heart motion in healthy obese compared to normal-weight volunteers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN33037282·No longer recruiting·Comparing two medications (dexamethasone and methylprednisolone high dose) for the treatment of pneumonia in patients with COVID-19
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN21363594·No longer recruiting·Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10077335·No longer recruiting·Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN32938630·No longer recruiting·Prediction of outcome in patients with lung impairment: a prospective comparison using different scores
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10085480·No longer recruiting·Electric muscle stimulation for treatment of functional shoulder instability
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11520709·Stopped·Efficacy and safety of Octanorm in patients with dermatomyositis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN48095567·No longer recruiting·Prevention of heart and lung complications by using simvastatin in patients undergoing surgery for removal of food pipe
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13838310·No longer recruiting·Programmable versus fixed anti-siphon devices for normal pressure hydrocephalus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN31630783·No longer recruiting·A clinical trial to investigate efficacy and safety of Menthacarin® in patients (at least 18 years old) suffering from symptoms of Irritable Bowel Syndrome (IBS)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65055502·No longer recruiting·Assessment of efficacy of mirabegron, a new beta3-adrenergic receptor in the prevention of heart failure
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18128385·No longer recruiting·Effect of the probiotic strain BB-12® on the gastrointestinal function of healthy adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN75434563·No longer recruiting·Mycophenolate mofetil versus cyclophosphamide for the induction of remission of childhood polyarteritis nodosa
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome" OR "Berlin syndrome" OR "Ectodermal dysplasia, Berlin type" OR "LEUKOMELANODERMA, infantilism, intellectual disability, hypodontia, hypotrichosis" OR "LEUKOMELANODERMA, infantilism, mental retardation, hypodontia, hypotrichosis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome" OR "Berlin syndrome" OR "Ectodermal dysplasia, Berlin type" OR "LEUKOMELANODERMA, infantilism, intellectual disability, hypodontia, hypotrichosis" OR "LEUKOMELANODERMA, infantilism, mental retardation, hypodontia, hypotrichosis"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T18:13:54.345Z
